Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 13,865,000 | 12,225,000 | 15,121,000 | 14,812,000 | 14,583,000 |
| Cost of Goods | 4,240,000 | 3,986,000 | 4,170,000 | 5,022,000 | 4,170,000 |
| Gross Profit | 9,625,000 | 8,239,000 | 10,951,000 | 9,790,000 | 10,413,000 |
| Operating Expenses | 5,112,000 | 5,471,000 | 5,449,000 | 5,187,000 | 7,118,000 |
| Operating Income | 4,513,000 | 2,768,000 | 5,502,000 | 4,603,000 | 3,295,000 |
| Interest Expense | 454,000 | 454,000 | 476,000 | 497,000 | 532,000 |
| Other Income | -1,449,000 | -1,839,000 | -2,061,000 | 294,000 | -1,580,000 |
| Pre-tax Income | 2,610,000 | 475,000 | 2,965,000 | 4,400,000 | 1,183,000 |
| Income Tax | 583,000 | 234,000 | 493,000 | 448,000 | 255,000 |
| Net Income Continuous | 2,027,000 | 241,000 | 2,472,000 | 3,952,000 | 928,000 |
| Minority Interests | 3,000 | 2,000 | -1,000 | 3,000 | 4,000 |
| Net Income | $2,024,000 | $239,000 | $2,473,000 | $3,949,000 | $924,000 |
| EPS Basic Total Ops | 1.14 | 0.13 | 1.39 | 2.22 | 0.52 |
| EPS Basic Continuous Ops | 1.15 | 0.14 | 1.40 | 2.23 | 0.52 |
| EPS Diluted Total Ops | 1.14 | 0.13 | 1.40 | 2.21 | 0.51 |
| EPS Diluted Continuous Ops | 1.14 | 0.14 | 1.39 | 2.23 | 0.52 |
| EPS Diluted Before Non-Recurring Items | 2.91 | 2.46 | 3.60 | N/A | N/A |
| EBITDA(a) | $6,773,000 | $4,895,000 | $7,659,000 | $6,808,000 | $5,347,000 |